VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 1 filers reported holding VALEANT PHARMACEUTICALS INTL in Q3 2023. The put-call ratio across all filers is - and the average weighting 2.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $3,182,000 | -28.7% | 17,839 | -11.2% | 0.15% | -21.5% |
| Q2 2015 | $4,461,000 | +177.3% | 20,081 | +147.9% | 0.19% | +204.9% |
| Q1 2015 | $1,609,000 | +523.6% | 8,101 | +350.1% | 0.06% | +408.3% |
| Q4 2014 | $258,000 | -97.9% | 1,800 | -98.1% | 0.01% | -97.7% |
| Q3 2014 | $12,516,000 | -41.2% | 95,400 | -43.5% | 0.53% | -41.6% |
| Q2 2014 | $21,302,000 | +25.5% | 168,900 | +31.1% | 0.90% | +29.4% |
| Q1 2014 | $16,980,000 | – | 128,800 | – | 0.70% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACCIPITER CAPITAL MANAGEMENT, LLC | 2,106,379 | $55,398,000 | 31.67% |
| Claren Road Asset Management, LLC | 80,000 | $2,820,000 | 24.27% |
| Okumus Fund Management Ltd. | 3,722,464 | $97,901,000 | 15.82% |
| Wingspan Investment Management, LP | 852,900 | $22,431,000 | 12.66% |
| FARLEY CAPITAL L.P. | 307,458 | $8,086,000 | 11.46% |
| Chou Associates Management | 976,843 | $25,725,000 | 8.35% |
| Wingspan Investment Management, LP | 550,700 | $14,483,000 | 8.17% |
| HAP Trading, LLC | 4,043,900 | $109,610,000 | 8.00% |
| LeVasseur Capital Partners LLC | 128,269 | $3,373,000 | 6.97% |
| Pershing Square Capital Management | 21,591,122 | $567,847,000 | 6.41% |